Stockscreener 앱 받기
7.16
2.43%
0.17
시간 외 거래:
7.12
-0.04
-0.56%
전일 마감가:
$6.99
열려 있는:
$6.85
하루 거래량:
406.16K
Relative Volume:
1.06
시가총액:
$76.27M
수익:
$3.36M
순이익/손실:
$-7.54M
주가수익비율:
-7.0024
EPS:
-1.0225
순현금흐름:
$-6.28M
1주 성능:
+10.49%
1개월 성능:
+33.83%
6개월 성능:
+181.89%
1년 성능:
+212.66%
1일 변동 폭
$6.04
$7.2105
1주일 범위
$6.04
$7.46
52주 변동 폭
$1.33
$7.46
Neuraxis Inc Stock (NRXS) Company Profile
명칭
Neuraxis Inc
전화
(812) 689-0791
주소
11550 North Meridian Street, Suite 325, Carmel
Compare NRXS vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NRXS
Neuraxis Inc
|
7.16 | 74.46M | 3.36M | -7.54M | -6.28M | -1.0225 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.05 | 114.72B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
737.45 | 78.67B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
684.50 | 42.38B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
311.10 | 41.75B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
282.72 | 31.33B | 5.36B | 287.73M | 924.18M | 2.5229 |
Neuraxis Inc 주식(NRXS)의 최신 뉴스
Earnings call transcript: NeurAxis Q4 2025 sees revenue growth, stock dips - Investing.com
NRXS: FY2025 revenue rose 33% to $3.6M, with improved net loss and expanded market access - TradingView
NeurAxis Reports Strong Fourth Quarter and Full Year 2025 Financial Results - Bluefield Daily Telegraph
Neuraxis 10-K: $3.57M Revenue, $(7.80)M Net Loss - TradingView
NeurAxis says its pain-treatment device now reaches 100M insured lives - Stock Titan
Neuraxis (NRXS) expands IB-Stim GI neuromodulation, RED constipation device and IP moat - Stock Titan
Levels Update: Should I trade or invest in NeurAxis Inc2026 Top Gainers & Expert Curated Trade Ideas - baoquankhu1.vn
Analysts Offer Insights on Healthcare Companies: NeurAxis, Inc. (NRXS), Argenx Se (ARGX) and Teladoc (TDOC) - The Globe and Mail
Aug Ideas: What is the implied volatility of NeurAxis Inc2026 Fed Impact & Reliable Volume Spike Trade Alerts - baoquankhu1.vn
NeurAxis, Inc. Hits New 52-Week High of $7.46, Up 141.44% - Markets Mojo
Breakout Zone: Is NeurAxis Inc impacted by rising ratesTrade Exit Report & Stock Portfolio Risk Control - baoquankhu1.vn
NeurAxis, Inc. Hits New 52-Week High at USD 7.34 - Markets Mojo
Neuraxis price target raised to $8 from $7 at Craig-Hallum - MSN
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
NeurAxis to Host Fourth Quarter and Full Year 2025 Results and Business Update Call on Thursday, March 19, 2026 - Sahm
Medical tech firm NeurAxis schedules March 19 call on 2025 results - Stock Titan
Stock List: Research Stocks from Around the World - GuruFocus
NeurAxis (NASDAQ:NRXS) Shares Up 0.7%Still a Buy? - MarketBeat
NeurAxis, Inc. Hits New 52-Week High of $6.35, Up 98.97% - Markets Mojo
Volume Recap: Can TTWO expand its profit marginsJuly 2025 Action & Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
How FlexShares iBoxx 3 Year Target stock trades in high volatilityMarket Activity Summary & Reliable Price Breakout Signals - Naître et grandir
Update Recap: Should you avoid OSCR stock right now2025 Macro Impact & Entry Point Confirmation Alerts - baoquankhu1.vn
Aug Highlights: Can NeurAxis Inc stock outperform in a bear marketJuly 2025 Final Week & Real-Time Chart Breakout Alerts - baoquankhu1.vn
Chronic Idiopathic Constipation Pipeline 2026: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | ABBVIE, Eisai Co, Anji Pharma, Yuhan, Renexxion Ireland - Barchart.com
AI Investing InsightsOfficial HomepageIntellectia AI™ - Intellectia AI
00152 Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
NeurAxis, Inc. Hits New 52-Week High of $6.30, Up 115.75% - Markets Mojo
S32 Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
BPCF Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
NRXS Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Neuraxis (NRXS) awards 47,569 RSUs to senior executive Miranda - Stock Titan
P 500Share Buyback & Expert Approved Trade Ideas - mfd.ru
NRXS Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Director at Neuraxis (NRXS) receives 21,598-share equity grant as compensation - Stock Titan
Neuraxis (NRXS) CEO granted 94,173 RSUs in three-year vesting award - Stock Titan
SMN Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
LINK Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Volume Report: Can NeurAxis Inc stock outperform in a bear marketGap Down & Accurate Trade Setup Notifications - baoquankhu1.vn
NRXSNeuraxis Inc Latest Stock News & Market Updates - Stock Titan
Is NeurAxis Inc. impacted by rising rates2025 Price Momentum & Free Expert Verified Stock Movement Alerts - mfd.ru
Is NeurAxis Inc. in a consolidation phaseJuly 2025 Closing Moves & Reliable Price Breakout Signals - mfd.ru
What is the earnings history of Nuwellis Inc.2025 Pullback Review & Weekly Return Optimization Alerts - mfd.ru
Why MicroCloud Hologram Inc. stock attracts global investorsJuly 2025 PostEarnings & Intraday High Probability Setup Alerts - mfd.ru
Why Neuraxis Inc. stock could outperform next yearWeekly Gains Report & Free Community Supported Trade Ideas - mfd.ru
Institution Moves: Can NeurAxis Inc reach all time highs this yearWeekly Volume Report & Risk Managed Investment Signals - baoquankhu1.vn
Analysts Offer Insights on Healthcare Companies: NeurAxis, Inc. (NRXS), Janux Therapeutics Inc (JANX) and BioLife Solutions (BLFS) - The Globe and Mail
09999 Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Aug Outlook: What is the cash position of PSAPRF2025 Bull vs Bear & Safe Entry Momentum Tips - baoquankhu1.vn
Will NeurAxis Inc. stock maintain growth storyJuly 2025 Fed Impact & Low Risk Entry Point Guides - mfd.ru
Can GMIIW weather a recession2025 Investor Takeaways & Real-Time Volume Spike Alerts - mfd.ru
Neuraxis Inc (NRXS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.20%
0.06%
자본화:
|
볼륨(24시간):